On June 9, 2014, CONTINUUS Pharmaceuticals closed its Series A financing round of $2 M, increasing the total capital raised to over $2.4 M. The round was led by CONTINUUS’s new strategic partner I.M.A. Industria Macchine Automatiche. I.M.A. is a global leader in the manufacturing of pharmaceutical equipment and will contribute its expertise towards the commercialization of CONTINUUS’s novel manufacturing process and supporting the development of novel equipment. Previous seed investors also participated in this round. This transaction triggered the execution of an exclusive license on several novel continuous manufacturing technologies developed at MIT.